Investor Overview




Arena is a biopharmaceutical company focused on discovering and developing novel, small molecule drugs. We are currently directing our activities and resources primarily on:


Frequently Asked Questions

How will Arena report on BELVIQ sales?
Are BELVIQ prescription numbers tracked and reported on during the quarter?
When does Arena's fiscal year end?
How can I get added to Arena's mailing list?
Does Arena offer a direct stock purchase plan?


Stock Information
Ticker:
ARNA
Exchange:
NASDAQ
Price:
1.74
Change:
0.00
Open:
1.73
Previous Close:
1.74
Day High:
1.74
Day Low:
1.73
52-week High:
2.68
52-week Low:
1.30
Stock price graph
     
Delayed at least 20 minutes. Provided by eSignal.

 

Featured Report
PDF  2015 Annual Report
Receive Email Alerts
Click here to sign up for email alerts 


Recent Releases RSS  View All »

Sep 1, 2016
Arena Pharmaceutics Announces Formation of Beacon Discovery

Aug 15, 2016
Arena Pharmaceuticals Announces Appointment of Vincent Aurentz as Chief Business Officer

Events & Presentations View All »

There are no upcoming events available at this time.